Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

ReQuip XL prolonged-release tablets

Active Ingredient:
ropinirole
Company:  
GlaxoSmithKline UK See contact details
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Live Chat HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 26 Jul 2023
{pdf} View or print the patient leaflet as PDF
GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]